Provider assessment of adherence to HIV antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 26, Issue 5, 2001, Pages 435-442

  Bangsberg, David R ^a,b   Hecht, Frederick M ^a   Clague, Heather ^a   Charlebois, Edwin D ^b   Ciccarone, Dan ^c   Chesney, Margaret ^c   Moss, Andrew ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adherence; Drug use; Health care provider; Highly active antiretroviral therapy; HIV; Homeless; Pill count; Self report

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; CLINICAL ARTICLE; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; SELF REPORT; SENSITIVITY AND SPECIFICITY;

EID: 0035870745     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200104150-00005     Document Type: Article

References (33)

1. Vanhove GF, Schapiro JM, Winters MA, et al. Patient compliance and drug failure in protease inhibitor monotherapy [letter]. JAMA 1996;276:1955-6.
2. Haubrich RH, Little SJ, Currier JS, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS 1999;13:1099-107.
3. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000;14:357-66.
4. Gifford AL, Bormann JE, Shively MJ, et al. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Svndr 2000;23:386-95.
5. Catz SL, Kelly JA, Bogart LM, et al. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol 2000;19:124-33.
6. Descampes D, Flandre P, Calvez V, et al. Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. JAMA 2000; 283: 205-11.
7. Havlir DV, Hellmann NS, Petropoulos CJ, et al. Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens. JAMA 2000;283:229-34.
8. Craig HM. Accuracy of indirect measures of medication compliance in hypertension. Res Nurs Health 1985;8:61-6.
9. Lee JY, Kusek JW, Greene PG, et al. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens 1996;9:719-25.
10. Matsui D, Hermann C, Klein J, et al. Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator. J Clin Pharmacol 1994;34: 944-9.
11. Paes AH, Bakker A, Soe-Agnie CJ. Measurement of patient compliance. Pharm World Sci 1998;20:73-7.
12. Waterhouse DM, Calzone KA, Mele C, et al. Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol 1993;11:1189-97.
13. Fletcher SW, Pappius EM, Harper SJ, Measurement of medication compliance in a clinical setting. Comparison of three methods in patients prescribed digoxin. Arch Intern Med 1979;139:635-8.
14. Gilbert JR, Evans CE, Haynes RB, et al. Predicting compliance with a regimen of digoxin therapy in family practice. Can Med Assoc J 1980;123:119-22.
15. Mushlin AI, Appel FA. Diagnosing potential noncompliance. Physicians' ability in a behavioral dimension of medical care. Arch Intern Med 1977;137:318-21.
16. Caron HS, Roth HP. Patients' cooperation with a medical regimen. Difficulties in identifying the noncooperator. JAMA 1968;203: 922-6.
17. Charney E, Bynum R, Eldredge D, et al. How well do patients take oral penicillin? A collaborative study in private practice. Pediatrics 1967;40:188-95.
18. Steiner J, F. Provider assesment of compliance with zidovudine. Arch Intern Med 1995;155:335-6.
19. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
20. Zolopa AR, Hahn JA, Gorter R, et al. HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample. JAMA 1994;272:455-61.
21. Bangsberg DR, Hecht FM, Charlebois E, et al. Comparing objective methods of adherence assessment: electronic medication monitoring and unannounced pill count. AIDS Behav 2001, in press.
22. Kastrissios H, Suarez JR, Katzenstein D, et al. Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial. AIDS 1998;12:2295-303.
23. Chesney MA, Ickovics J, Hecht FM, et al. Adherence: a necessity for successful HIV combination therapy. AIDS 1999;13(Suppl A):S271-8.
24. Lopez-Suarez A, Fernandez-Gutierrez del A, Perez-Guzman E, et al. Adherence to the antiretroviral treatment in asymptomatic HIV-infected patients [letter]. AIDS 1998;12:685-6.
25. Eldred LJ, Wu AW, Chaisson RE, et al. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:117-25.
26. Lerner BH, Gulick RM, Dubler NN. Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease. Ann Intern Med 1998;129:573-8.
27. Bangsberg D, Hecht F, Charlebois E, et al. Spontaneous adherence audits predict viral suppression in the REACH cohort. 6th Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, U.S.A., 1999.
28. Sontag D. Doctors withhold HIV pill regimen from some. New York Times 1997(March 2):A1.
29. Bogart LM, Kelly JA, Catz SL, et al. Impact of medical and non-medical factors on physician decision making for HIV/AIDS antiretroviral treatment. J Acquir Immune Defic Svndr 2000;23: 396-404.
30. Roberts KJ, Volberding P. Adherence communication: a qualitative analysis of physician-patient dialogue. AIDS 1999;13:1771-8.
31. Gerbert B, Abercombie P, Bronstone A, et al. Challenges in adherence: the providers' perspective. AIDS Care 2000;12:409-21.
32. Des Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet 1999;353:1657-61.
33. Bangsberg DR, Bronstone A, Hoffman R. A computer-based assessment detects regimen misunderstandings and nonadherence for patients on HIV antiretroviral therapy. AIDS Care 2002, in press.